BenjaminMatthewSegalMD

Summary

• Benjamin Segal, MD, is a leader and clinician-scientist at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine. He is Chair of the Department of Neurology, Director of the Neuroscience Research Institute, and co-director of the Neurological Institute (NI). The NI combines five neuroscience-related specialties into one integrated program in order to accelerate innovation and promote collaborations in patient care and research. As the Stanley D. and Joan H. Ross Endowed Professor of Neurology, Dr. Segal is actively involved in training the next generation of physicians and scientists who treat and study neurological disorders. At the international level, he serves on the Board of Directors of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS). He is founder and organizer of the annual ACTRIMS Neurology Resident and Young Investigator Summits, and he chaired the Scientific Program Committee of the 2020 ACTRIMS/ECTRIMS meeting, which is the largest international academic meeting on MS and related disorders. Named among the Best Doctors in America for over ten years, Dr. Segal is internationally recognized for his work in Multiple Sclerosis (MS) and neuroimmunology. With annual NIH funding for his ongoing research programs in excess of $1.3 million, his discoveries have contributed to the basic understanding of the pathogenesis of MS and similar diseases. Dr. Segal has received innumerable awards, including the prestigious Harry Weaver Neuroscience Scholar award from the National Multiple Sclerosis Society and the Commendation Medal for Excellence from the Public Health Service. He has lectured nationally and internationally and served on multiple NIH study sections, including co-chairing the major review panel in his field. He holds several patents and is a member of every major organization in neurology.